NL-OMON32543撤回4 期
Telbivudine monotherapy for HIV-HBV coinfected patients: an open explorative study. - THH
niversitair Medisch Centrum Utrecht0 个研究点目标入组 35 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 撤回
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •HIV infected no HAART and HBV infected needing treatment
排除标准
- •HAART indicated
研究者
相似试验
撤回
不适用
Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIVHIV InfectionsHepatitis BNCT00051090National Institute of Allergy and Infectious Diseases (NIAID)
已完成
1 期
TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted ReproductionHepatitis B, ChronicNCT02338674Fuzhou General Hospital121
Unknown
4 期
Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot StudyChronic Hepatitis BNCT01804387Korea University60
已完成
4 期
A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB)Hepatitis B, ChronicNCT00651209Novartis Pharmaceuticals105
进行中（未招募）
不适用
A Randomized, Double-Blind Trial of Telbivudine (LdT) versus Lamivudine in Adults with Decompensated Chronic Hepatitis B and Evidence of CirrhosisEUCTR2004-000443-17-LVIdenix Pharmaceuticals, Inc.270